Market Research Logo

Musculoskeletal Drugs Market Global Briefing 2018 Including: Musculoskeletal Drugs, Muscle Relaxants, Drugs For Rheumatoid ArthritisCovering: F. Hoffmann-La Roche Ltd., GlaxosmithKline Plc., Pfizer Inc., Daiichi Sankyo Company, Limited, Abbott Laboratorie

Musculoskeletal Drugs Market Global Briefing 2018 Including: Musculoskeletal Drugs, Muscle Relaxants, Drugs For Rheumatoid ArthritisCovering: F. Hoffmann-La Roche Ltd., GlaxosmithKline Plc., Pfizer Inc., Daiichi Sankyo Company, Limited, Abbott Laboratories Inc., Johnson & Johnson, Sanofi S.A., Novartis AG, Otsuka Pharmaceutical Co., Ltd., Celgene Corporation

North America was the largest region in the musculoskeletal disorders drugs market in 2017, accounting for around 32% market share. This can be attributed to the high per capita healthcare expenditure and the development of cost effective drugs for musculoskeletal disorders. Western Europe was the second largest region accounting for around 22.5% market share. Asia Pacific was the third largest region accounting for around 22% market share.

Musculoskeletal Drugs Market Global Briefing 2018 provides strategists, marketers and senior management with the critical information they need to assess the global musculoskeletal drugs sector.

Reasons to Purchase

  • Fully updated for 2018.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.
Description

Musculoskeletal Drugs Market Global Briefing 2018 from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the musculoskeletal drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the musculoskeletal drugs market and suggests approaches.

Scope

Markets Covered: Drugs For Rheumatoid Arthritis, Muscle Relaxants, Others.

Companies Mentioned: F. Hoffmann-La Roche Ltd., GlaxosmithKline Plc., Pfizer Inc., Daiichi Sankyo Company Limited, Abbott Laboratories Inc., Johnson & Johnson, Sanofi S.A., Novartis AG, Otsuka Pharmaceutical Co., Ltd., Celgene Corporation

Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


Musculoskeletal Drugs Market Characteristics
Musculoskeletal Drugs Market Historic Growth (2013-17)
Musculoskeletal Drugs Market Forecast Growth (2017-21)
Musculoskeletal Drugs Market Segmentation
Global Musculoskeletal Drugs Market, Split By Segments, 2017, $ Billion
Drugs for Rheumatoid Arthritis
Muscle Relaxants
Others
Global Musculoskeletal Drugs Market, Historic and Forecast, Split By Segments, 2013-2021
Musculoskeletal Drugs Market Geography Regional and Country Comparison
Global Musculoskeletal Drugs Market, Split By Regions, 2017
Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2013-2021
Global Musculoskeletal Drugs Market, Split By Country, 2017
Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021
Musculoskeletal Drugs Market Competitive Landscape
F. Hoffmann-La Roche Ltd.
GlaxosmithKline Plc.
Pfizer Inc.
Abbott Laboratories Inc.
Daiichi Sankyo Company, Limited
Johnson & Johnson
Sanofi S.A.
Novartis AG
Otsuka Pharmaceutical Co., Ltd.
Celgene Corporation
F.Hoffmann-La Roche
GlaxoSmithKline
Pfizer
Musculoskeletal Drugs Market Key Mergers And Acquisitions
AbbVie Acquired Pharmacyclics
Valeant Acquired Salix Pharmaceuticals
Roche Acquired Adheron Therapeutics
Musculoskeletal Drugs Market Trends And Strategies
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) For Acute Musculoskeletal Pain
New Drug Delivery Technologies
Use of Muscle Relaxants in New Indications
Appendix
NAICS Definitions Of Industry Covered In This Report
Definition Of Market Covered In This Report
Abbreviations
Currencies
Research Methodology
Research Inquiries
The Business Research Company
List of Figures
Figure 1: Global Musculoskeletal Drugs Market, Historic Market Size, 2013-2017, $ Billion
Figure 2: Global Musculoskeletal Drugs Market, Forecast Market Size, 2017 – 2021, $ Billion
Figure 3: Global Musculoskeletal Drugs Market, Split By Segments, 2017, $ Billion
Figure 4: Global Musculoskeletal Drugs Market, Historic and Forecast, Split By Segment, 2013 – 2021
Figure 5: Global Musculoskeletal Drugs Market, Split By Region, 2017, $ Billion
Figure 6: Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2013-2021
Figure 7: Global Musculoskeletal Drugs Market, Split By Country, 2017, $ Billion
Figure 8: Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021
Figure 9: Global Musculoskeletal Drugs Market, Key Competitor Estimated Market Shares, 2017, Percentage (%)
List of Tables
Table 1: Global Musculoskeletal Drugs Market, Historic Market Size, 2013-2017, $ Billion
Table 2: Global Musculoskeletal Drugs Market, Forecast Market Size, 2017 – 2021, $ Billion
Table 3: Global Musculoskeletal Drugs Market, Split By Segments, 2017, $ Billion
Table 4: Global Musculoskeletal Drugs Market, Historic and Forecast, Split By Segment, 2013 – 2021
Table 5: Global Musculoskeletal Drugs Market, Split By Region, 2017, $ Billion
Table 6: Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020
Table 7: Global Musculoskeletal Drugs Market, Split By Country, 2017, $ Billion
Table 8: Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2013-2021
Table 9: Global Musculoskeletal Drugs Market, Key Competitor Estimated Market Shares, 2017, Percentage (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report